Dihydroergotamine Recruiting Phase 2 Trials for Migraine in Children Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT03885154Valproic Acid and Dihydroergotamine as Abortive Therapy in Pediatric Migraine